Top 11 medical and healthcare startups in Amsterdam
Apr 08, 2026
|
Like
18
1
Funding: $1.3B
uniQure has developed an industry-leading AAV gene therapy platform focused on liver and central nervous system diseases. The company's lead candidate, AMT-130, for the treatment of Huntington's disease consists of an AAV5 vector carrying an artificial micro-RNA specifically tailored to silence the huntingtin gene. The therapeutic goal is to inhibit the production of the mutant protein. The company is also developing candidate AMT-191 for Fabry disease (it delivers a GLA transgene to the liver to enhance GLA protein production), AMT-162 for the treatment of amyotrophic lateral sclerosis (ALS) caused by mutations in the SOD1 gene (it is a recombinant AAVrh10 vector expressing microRNA designed to suppress SOD1 expression) and HEMGENIX - the world's first FDA-approved gene therapy for hemophilia B.
uniQure has developed an industry-leading AAV gene therapy platform focused on liver and central nervous system diseases. The company's lead candidate, AMT-130, for the treatment of Huntington's disease consists of an AAV5 vector carrying an artificial micro-RNA specifically tailored to silence the huntingtin gene. The therapeutic goal is to inhibit the production of the mutant protein. The company is also developing candidate AMT-191 for Fabry disease (it delivers a GLA transgene to the liver to enhance GLA protein production), AMT-162 for the treatment of amyotrophic lateral sclerosis (ALS) caused by mutations in the SOD1 gene (it is a recombinant AAVrh10 vector expressing microRNA designed to suppress SOD1 expression) and HEMGENIX - the world's first FDA-approved gene therapy for hemophilia B.
2
Funding: €160M
VectorY Therapeutics develops gene therapies against amyotrophic lateral sclerosis (ALS) and Alzhiemer’s disease.
VectorY Therapeutics develops gene therapies against amyotrophic lateral sclerosis (ALS) and Alzhiemer’s disease.
3
Funding: $64.4M
Castor offers a cloud-based clinical data platform that simplifies and streamlines clinical trials processes.
Castor offers a cloud-based clinical data platform that simplifies and streamlines clinical trials processes.
4
Funding: €37.6M
Scenic Biotech is a developer of a genomics and immunotherapy technologies created to unlock genetic suppressors.
Scenic Biotech is a developer of a genomics and immunotherapy technologies created to unlock genetic suppressors.
5
Funding: $16.5M
SkinVision is a mobile app that allows you to understand your risk factors for skin cancer and keep track of your moles.
SkinVision is a mobile app that allows you to understand your risk factors for skin cancer and keep track of your moles.
6
Funding: €14M
Siilo is a secure and compliant messaging and collaboration for healthcare teams.
Siilo is a secure and compliant messaging and collaboration for healthcare teams.
7
Funding: $13.4M
An online fitness platform for consumers & professionals in the health industry
An online fitness platform for consumers & professionals in the health industry
8
Funding: $7.4M
Lapsi Health is a Medical Technology company developing Digital Biomarkers from medical sound analytics. In particular it develops digital stethoscope for detecting childhood asthma.
Lapsi Health is a Medical Technology company developing Digital Biomarkers from medical sound analytics. In particular it develops digital stethoscope for detecting childhood asthma.
9
Funding: $4.1M
Women's health clinics specialised in fast diagnostics, treatments, surgery and outpatient services for and by women. All supported by our SHE. telehealth app for 24/7 care support
Women's health clinics specialised in fast diagnostics, treatments, surgery and outpatient services for and by women. All supported by our SHE. telehealth app for 24/7 care support
10
Funding: €1M
Skinive's goal is to provide personalized advice and prevent dangerous skin diseases among people.
Skinive's goal is to provide personalized advice and prevent dangerous skin diseases among people.
11
Traverse Health is a pioneering company at the intersection of healthcare data and artificial intelligence. We specialize in organizing and analyzing real-world data sourced from Electronic Health Records. Our insights empower pharmaceutical and biotech companies, healthcare providers, and policymakers to enhance patient outcomes. What sets us apart is our exclusive access to crucial data on specific patient populations and diseases, which are otherwise unavailable in the market.
★
See also:
